Contract manufacturing (CDMO) step by step: How to successfully launch your own new product on the market?

The production of dietary supplements, medicines, or innovative cosmetics consumes enormous resources, both financial and time-related. In the face of dynamically changing legal regulations and growing consumer expectations, building production facilities independently and bringing a product to market is becoming an insurmountable barrier for many companies. The answer to these challenges is CDMO (Contract Development and Manufacturing Organization) outsourcing, i.e., entrusting the technological process to an experienced business partner. Professional contract manufacturing saves time, reduces operating costs, and allows brand owners to focus solely on sales planning and development.

Step 1: Concept, brand strategy, and market analysis

Every successful market launch begins with a solid strategy. The first step is always an in-depth analysis of customer needs, market specifics, and the target category. At this stage, the priority is to precisely define the Unique Selling Proposition (Unique Selling Proposition – USP), which will give the product a competitive advantage and market success.

In a model such as the contract manufacturing of cosmetics, supplements, or medicines, an experienced partner helps prepare the strategy, ensuring that the brand vision is consistent with current trends and technological capabilities. A strong start helps avoid mistakes at later stages and optimizes time-to-market, i.e., the period from the start of work (or the creation of the idea) to the market debut and making the product available to customers.

Step 2: Research and Development (R&D) – from formulation to validation

The heart of innovation beats in the research laboratory. R&D (Research & Development) is much more than simply mixing ingredients. Proprietary formulations are created in research laboratories, based on rigorous supplier qualification and the selection of materials of the highest, certified quality.

In our Galenic Laboratory, the creation of a modern formula is based on three pillars:

• material analysis: Ingredients are selected for purity, stability, and bioavailability so that they retain their properties throughout the entire shelf life;
• stability testing: The formulation is exposed to varying temperature, humidity, and light conditions (long-term and accelerated tests), which allows the formula to be improved, if necessary, before implementation;

The final, no less important element of this stage is validation of the technological process, which guarantees that each subsequent batch produced on a mass scale will be identical to the laboratory standard.

Step 3: Optimal selection of the production form (dry and wet)

Modern technologies in contract manufacturing make it possible to implement almost any product vision. Customers can choose from a variety of pharmaceutical manufacturing forms suitable for medicines, supplements, or cosmetics. The following are available:

• dry forms: loose mixtures, sachets, hard capsules, various tablets (round, oblong, coated);
• wet and semi-liquid forms: solutions, syrups, drops, emulsions, as well as specialist ointments, gels, creams, pessaries, and suppositories.

Good to know

At Eubioco, we offer the innovative Eubiocap technology (capsule-in-capsule), ideal for formulas requiring sequential release of ingredients. Our partners can choose from a wide range of forms of medicines and dietary supplements, benefiting from access to unique technological solutions and the most advanced standards of contract manufacturing.

Step 4: Support in registration and system documentation

The complexity of legal regulations is often the most difficult barrier on the way to bringing a product to market. At Eubioco, as your CDMO partner, we provide full support in preparing rigorous registration documentation tailored to the specific nature and status of your product:

• Production of dietary supplements: we coordinate the process of notifying products to the Chief Sanitary Inspectorate (GIS), ensuring the correctness of labels and health claims;
• Contract manufacturing of cosmetics: we provide full support in the European CPNP portal and prepare the Safety Report;
• Contract manufacturing of medical devices and medicines: we offer expert support in the registration of medical devices in the EUDAMED and URPL databases, as well as registration support for medicinal products under various procedures, ensuring compliance with the highest safety standards.

Good to know

Professional regulatory support at the implementation stage is not merely a formality, but above all a way to secure sales continuity and protect your brand’s reputation. You can learn more about legal requirements and certification procedures on our website; we invite you to visit the Knowledge Base section.

Step 5: Production scaling and rigorous Quality Control

Once the formulation successfully passes testing, the mass production stage begins. At Eubioco, we use an advanced machine park and IT systems (ARIEL, EPIONE), which eliminates the risk of human error. Safety is also guaranteed by rigorous standards applied at every stage – from the receipt of materials to the finished product:

• GMP certificate (Good Manufacturing Practice);
• HACCP system;
• ISO 22000:2018 standard (Food safety management).

Good to know

Laboratorium Galenowe Olsztyn, part of the Eubioco group, holds a GMP certificate valid until 2028, confirming the highest manufacturing standards.

Step 6: Packaging design and co-packing

Well-designed packaging should not only catch the consumer’s eye, but above all protect the product from factors that may affect its quality and efficacy (light, moisture, and contamination). Co-packing services should therefore be comprehensive and include:

• blister packaging (PVC, PVDC/ALU),
• co-packing of tablets and capsules,
• tube filling (aluminum and laminate tubes),
• packaging in individual and bulk cartons.   

The product packaging must also contain all necessary information, such as the composition, expiry date, directions for use, and warnings. All these elements must comply with the legal regulations in force in the market where the product is to be sold.

Good to know

By choosing to work with Eubioco, you gain comprehensive co-packing services, as well as design consulting and the assurance of legal compliance. Our experts verify labels for full compliance with the latest guidelines from supervisory authorities.

Step 7: Logistics and distribution compliant with GDP

The culmination of the process is GDP supply chain management. All warehousing and transport processes must be carried out in compliance with the rigorous requirements of Good Distribution Practice (GDP), with full tracking of the goods’ route. The ultimate safety of patients and end consumers depends precisely on strict adherence to these standards and a professional GDP chain.

Choose the End-to-End CDMO model and grow your business with Eubioco

Are you looking for an effective way to bring a product to market without investing millions in infrastructure? At Eubioco, we combine 35 years of experience with modern R&D facilities, offering tailor-made solutions – from the first concept, through material selection, all the way to a finished product on the shelf. Choosing the end-to-end model at Eubioco enables brand owners, pharmaceutical companies, and startups operating in the medical industry to significantly reduce operating costs and minimize product implementation time (time-to-market).

Our strengths include:

• full safety – we ensure compliance with EU legal requirements and quality standards;
• versatility – contract manufacturing of medicines, cosmetics, and supplements in one place;
• innovation – cooperation with Eubioco means access to modern production lines and advanced technologies (such as Eubiocap, for example);
• expert support – we guarantee regulatory, analytical, and design consulting.

BIBLIOGRAPHY

1. Investopedia (2025). What Is Research and Development (R&D)? [online]. Available at: https://www.investopedia.com/terms/r/randd.asp [online access: 06.05.2026]
2. National Science Foundation (2025). Definitions of Research and Development: An Annotated Compilation of Official Sources [online]. Available at: https://ncses.nsf.gov/pubs/ncses25215 [online access: 06.05.2026]
3. Act of 25 August 2006 on Food and Nutrition Safety (Journal of Laws of 2023, item 1225).
4. Act of 6 September 2001 – Pharmaceutical Law (Journal of Laws of 2024, item 686).